Basis of Presentation (Tables)

9 Months Ended

Mar. 31, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The Following Table Sets Forth the Computation of the Company's Basic and Diluted Net Income (Loss) per Share Attributable to Common Shareholders:

The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common shareholders:


	For the Three Months Ended March 31,						For the Nine Months Ended March 31,
	2026			2025			2026			2025
Net income (loss)	$	325		$	(5,375	)	$	(44,387	)	$	(7,995	)
Adjust: Net (loss) attributable to noncontrolling interest		(344	)		(78	)		(1,774	)		(177	)
Net income (loss) available to participating securities		669			(5,297	)		(42,613	)		(7,818	)
Net (loss) attributable to vested shares of ECRC Class B common stock		(209	)		(41	)		(887	)		(591	)
Net income (loss) attributed to common shareholders - basic and diluted	$	878		$	(5,256	)	$	(41,726	)	$	(7,227	)
Denominator:
Weighted average shares outstanding – basic		132,104,478			45,893,738			107,785,668			41,777,986
Weighted average shares outstanding – diluted		136,150,592			45,893,738			107,785,668			41,777,986
Income (loss) per Common Share outstanding – basic	$	0.01		$	(0.11	)	$	(0.39	)	$	(0.17	)
Income (loss) per Common Share outstanding – diluted		0.01			(0.11	)		(0.39	)		(0.17	)

Schedule of Excluded From the Dilutive Securities


	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
Excluded potentially dilutive securities (1)(2):	2026		2025		2026		2025
Options		327,500		3,073,000		4,397,500		3,073,000
Warrants (3)		15,666,526		29,520,695		19,101,667		29,520,695
Total potentially dilutive securities		15,994,026		32,593,695		23,499,167		32,593,695

(1)

The number of shares is based on the maximum number of shares issuable on exercise of the related securities as of the period end. For the three months ended March 31, 2026, amounts reflect only those securities excluded as antidilutive. In-the-money securities have been evaluated under the treasury stock method and are included in diluted weighted average shares outstanding.

(2)

Earnout Shares (as defined in Note 6 below) are excluded as the vesting terms were not met as of the end of the reporting period.

(3)

Includes 15,666,526 NioCorp Assumed Warrants (as defined in Note 7c below) (March 31, 2025: 15,666,626) that are each exercisable into 1.11829212 Common Shares. The remaining Warrants are each exercisable into one Common Share.

(4)

For the three months ended March 31, 2026, 4,070,000 Options and 3,435,141 Warrants were determined to be dilutive under the treasury stock method and are included in the calculation of diluted weighted average Common Shares outstanding.

NIOCORP DEVELOPMENTS LTD 10-Q